We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ninety percent of MDD patients who did not adequately respond to pharmaceutical treatment showed improvement when using the device, the company said. Read More
“These certificates are not evidence that the manufacturer has met the regulatory requirements and should not be taken as proof of such,” the MHRA warned. Read More
One of the biggest downfalls of the MHRA during the pelvic mesh failure was not listening to patient concerns and responding too slowly, the report found. Read More